Zenodo · Apr 28, 2026

Metformin for Diabetes-Associated Cognitive Decline

By Engine MAD

Metformin activates AMPK, improving mitochondrial function and reducing oxidative stress in neurons. The drug also modulates insulin signaling and reduces advanced glycation end products, addressing metabolic dysfunction underlying diabetes-associated cognitive decline and potentially preventing progression to dementia.

doi.org/10.5281/zenodo.19832760Open accessInterventions

AgingResearch.News